Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

XENMATRIX™ AB Surgical Graft for the Repair of Severe Musculotendinous Tissue Damaged by Soft Tissue Trauma

NCT04051242 is registered in ClinicalTrials.gov with J. Peter Rubin, MD as lead sponsor.

NCT NCT04051242
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04051242 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
XENMATRIX™ AB Surgical Graft for the Repair of Severe Musculotendinous Tissue Damaged by Soft Tissue Trauma
Lead sponsor
J. Peter Rubin, MD
Phase
Not applicable
Overall status
Terminated
Start date
February 10, 2020
Completion date
January 24, 2024
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

muscle loss